StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note released on Friday. The brokerage issued a hold rating on the software maker’s stock.
Separately, TD Cowen cut their price target on shares of Veradigm from $26.00 to $15.00 and set a buy rating on the stock in a report on Tuesday, May 28th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Veradigm presently has a consensus rating of Hold and an average target price of $12.00.
View Our Latest Research Report on Veradigm
Veradigm Price Performance
Institutional Investors Weigh In On Veradigm
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. raised its stake in Veradigm by 8.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,087,605 shares of the software maker’s stock valued at $21,899,000 after acquiring an additional 171,199 shares during the period. Allianz Asset Management GmbH increased its position in shares of Veradigm by 41.2% during the fourth quarter. Allianz Asset Management GmbH now owns 343,433 shares of the software maker’s stock valued at $3,603,000 after buying an additional 100,275 shares during the period. Goldman Sachs Group Inc. increased its position in shares of Veradigm by 6.6% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker’s stock valued at $16,749,000 after buying an additional 99,528 shares during the period. Aigen Investment Management LP bought a new stake in shares of Veradigm during the fourth quarter valued at about $231,000. Finally, New York State Common Retirement Fund increased its position in shares of Veradigm by 4.4% during the fourth quarter. New York State Common Retirement Fund now owns 78,343 shares of the software maker’s stock valued at $822,000 after buying an additional 3,313 shares during the period.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Do ETFs Pay Dividends? What You Need to Know
- MarketBeat Week in Review – 9/2 – 9/6
- How to Read Stock Charts for Beginners
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.